Singapore Health News API

{
    "totalArticles": 49030,
    "articles": [
        {
            "id": "457f22414ee886c13bad70c65ab21f8d",
            "title": "Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic",
            "description": "First evidence of formulation-specific difference, significantly higher in men than women",
            "content": "The obesity drug semaglutide (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed.\nIn a review of 31,774 semagluti... [6346 chars]",
            "url": "https://www.medpagetoday.com/ophthalmology/generalophthalmology/120248",
            "image": "https://assets.medpagetoday.net/media/images/120xxx/120248.jpg",
            "publishedAt": "2026-03-10T22:30:32Z",
            "lang": "en",
            "source": {
                "id": "572d25e23e12ec1560e8ee1884a7057a",
                "name": "MedPage Today",
                "url": "https://www.medpagetoday.com"
            }
        },
        {
            "id": "9680e653cf26739112687772c6450d50",
            "title": "Blood Test May Predict Dementia in Women 25 Years Before Symptoms Appear",
            "description": "Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.",
            "content": "News\nA simple blood test might help predict a woman’s risk of dementia up to 25 years before any symptoms start, a new study suggests.\nThe blood test looks for elevated levels of a protein known as phosphorylated tau 217 (p-tau217) that can reveal br... [5638 chars]",
            "url": "https://www.everydayhealth.com/neurological-disorders/blood-test-may-predict-dementia-in-women-years-before-signs-appear/",
            "image": "https://images.everydayhealth.com/images/2026/new-blood-test-dementia-women-decades-early-440x810.jpg?sfvrsn=d48d8708_3",
            "publishedAt": "2026-03-10T20:48:45Z",
            "lang": "en",
            "source": {
                "id": "92d34f4629908817cb6cf6d0a120c5ff",
                "name": "Everyday Health",
                "url": "https://www.everydayhealth.com"
            }
        },
        {
            "id": "6d4bf2f1e9429749d98b4bb7e8db4429",
            "title": "GLP-1 Drugs and Osteoporosis; HbA1c at the Dentist? New Obesity Med Guide",
            "description": "News and commentary from the endocrinology world",
            "content": "GLP-1 receptor agonists may increase the risk of bone and tendon injuries, as well as conditions like osteoporosis and gout, a retrospective study suggested. (Washington Post)\nChairside HbA1c testing during routine dental visits identified diabetes i... [1929 chars]",
            "url": "https://www.medpagetoday.com/endocrinology/generalendocrinology/120239",
            "image": "https://assets.medpagetoday.net/media/images/120xxx/120239.jpg",
            "publishedAt": "2026-03-10T17:24:26Z",
            "lang": "en",
            "source": {
                "id": "572d25e23e12ec1560e8ee1884a7057a",
                "name": "MedPage Today",
                "url": "https://www.medpagetoday.com"
            }
        }
    ]
}